Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons

Affiliations

¹ Claire Mellon and Associates, Portland Hospital Consulting Rooms, London, England.
² Winton House, Stratford-Upon-Avon, England.
³ Translational Research Centre, UCL Institute for Women's Health, London, England.

Comment

Sarah Glynne et al. JAMA. 2023.

. 2023 Mar 21;329(11):940-941.

doi: 10.1001/jama.2023.0180.

¹ Claire Mellon and Associates, Portland Hospital Consulting Rooms, London, England.
² Winton House, Stratford-Upon-Avon, England.
³ Translational Research Centre, UCL Institute for Women's Health, London, England.

No abstract available

Comment in

Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Persons-Reply.
Mangione CM, Nicholson W, Stevermer J. Mangione CM, et al. JAMA. 2023 Mar 21;329(11):942-943. doi: 10.1001/jama.2023.0195. JAMA. 2023. PMID: 36943215 No abstract available.

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement.
US Preventive Services Task Force; Mangione CM, Barry MJ, Nicholson WK, Cabana M, Caughey AB, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaén CR, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Wong JB. US Preventive Services Task Force, et al. JAMA. 2022 Nov 1;328(17):1740-1746. doi: 10.1001/jama.2022.18625. JAMA. 2022. PMID: 36318127